Cash Flow from Operating Activities: A company's cash flows from operations.
Ligand Pharmaceuticals Incorporated (LGND) had Cash Flow from Operating Activities of $49.36M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$268.09M |
|
$124.45M |
|
$14.55M |
|
$253.54M |
|
$227.09M |
|
$41.00M |
|
$117.96M |
|
$158.96M |
|
$140.53M |
|
$124.45M |
|
$124.45M |
|
$124.45M |
|
$102.02M |
|
$41.00M |
|
$71.09M |
|
19.34M |
|
20.29M |
|
$6.44 |
|
$6.13 |
|
| Balance Sheet Financials | |
$832.27M |
|
-- |
|
$728.37M |
|
$1.56B |
|
$37.45M |
|
$446.19M |
|
$505.98M |
|
$543.42M |
|
$1.02B |
|
$690.23M |
|
$1.02B |
|
19.77M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$49.36M |
$-377.32M |
|
$428.22M |
|
$72.31M |
|
$174.93M |
|
$102.62M |
|
$46.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.23 |
|
-- |
|
-- |
|
0.30 |
|
0.44 |
|
94.57% |
|
15.29% |
|
15.29% |
|
26.52% |
|
59.29% |
|
46.42% |
|
$38.05M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
1.59 |
|
4.39 |
|
83.12 |
|
12.23% |
|
18.03% |
|
7.97% |
|
8.50% |
|
$51.44 |
|
$1.87 |
|
$2.43 |
|